Cancer genomics researcher Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, April 16, 2015

According to an MSK study, a powerful immunotherapy drug for lung cancer works better in people whose tumors carry a lot of mutations caused by tobacco smoke.

MSK investigators Joan Massagué and Anna Obenauf
In the Lab
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 9, 2015

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, April 1, 2015

Learn about five hot science areas that are changing the way we understand and treat cancer.

CAR T cell immunotherapy
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, March 31, 2015

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

Exceptional responders of new drugs in clinical trials.
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, March 24, 2015

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Christina Leslie and John Petrini
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, February 12, 2015

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, February 5, 2015

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.

Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Neurons created from embryonic stem cells
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 22, 2015

A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.

Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
In the Lab
By Christina Pernambuco-Holsten, MA, Managing Web Editor  |  Tuesday, December 30, 2014

From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.

Pictured: Eytan Stein
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 11, 2014

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

Pictured: Viviane Tabar
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 1, 2014

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

Michel Sadelain and Prasad Adusumilli
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 19, 2014

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, November 13, 2014

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

Center News

Stay Informed

Get the latest information about cancer care and research every month.